Back to Search
Start Over
Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts
- Source :
- Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 165-168 (2021)
- Publication Year :
- 2021
- Publisher :
- Столичная издательская компания, 2021.
-
Abstract
- The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of empagliflozin and its use in clinical practice in patients with chronic heart failure with reduced ejection fraction were accepted.
Details
- Language :
- English, Russian
- ISSN :
- 18196446 and 22253653
- Volume :
- 17
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Рациональная фармакотерапия в кардиологии
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.8642d167fac5420cbea6c65fee3a0b3e
- Document Type :
- article
- Full Text :
- https://doi.org/10.20996/1819-6446-2021-01-03